- No need to diet: Reducing protein intake can fight obesity
- Eisai/Bogen second Alzheimer’s drug has positive Phase 3 clinical results
- Why does Ebola virus become the ‘Replication Machine’?
- FDA Approved a Neurostimulation Therapy for Major Depressive Disorder
- What is the research progress of immunotherapy for Alzheimer’s disease?
- Protein linked to significantly increased risk of Alzheimer’s disease
Moderna COVID-19 vaccine 96% effective for 12-17 years old teens
Moderna COVID-19 vaccine 96% effective for 12-17 years old teens. Moderna said on May 06 2021 that preliminary data showed that the company’s COVID-19 vaccine is 96% effective for 12 to 17-year-olds, and there are no serious safety issues.
According to the report, 3235 teenagers aged 12 to 17 participated in Moderna’s Phase II clinical trial. These teenagers received at least one dose of the vaccine and had not previously been infected with the new coronavirus.
The company also announced on Wednesday that early data from an ongoing clinical trial showed that the “booster shot” of the new coronavirus vaccine it is developing has a good immune response to the first variant virus in South Africa and Brazil.
Canada approves Pfizer’s COVID-19 vaccine for 12 to 15-year-olds
Health Canada announced on the 5th that it has approved Pfizer’s COVID-19 vaccine for vaccination of people between 12 and 15 years old. Canada became the first country in the world to officially approve Pfizer’s COVID-19 vaccine for this age group.
Previously, Canada stipulated that Pfizer’s COVID-19 vaccine only applies to people 16 years of age and older. Up to now, Canada has approved the use of Pfizer, Moderna, AstraZeneca and Johnson & Johnson 4 COVID-19 vaccines, the latter three vaccines are limited to people 18 years and older.
Sharma, the chief medical adviser of Health Canada, said at a press conference that day that 20% of the confirmed COVID-19 cases in Canada so far are under 19 years of age. Although there are fewer severe cases among children and adolescents, vaccination for this age group is the key to Canada’s success in fighting the epidemic and helps control the spread of the new coronavirus.
According to data released by the Public Health Agency of Canada on the 5th, from April 28 to May 4, the average daily number of new coronavirus cases in Canada dropped by about 2%, but it was still as high as 7,852; the average daily death was 48.
According to a Canadian television report on the 5th, as of noon that day, the cumulative number of confirmed cases of COVID-19 in Canada exceeded 1.25 million, reaching 1,253,817 cases and a total of 24,445 deaths.
(source:internet, reference only)